Jane Street Group, LLC Repare Therapeutics Inc. Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$3.02 - $4.7 $15,244 - $23,725	-5,048 Reduced 29.81%	11,886 $39,000
Q1 2024 May 15, 2024	SELL	$4.53 - $8.41 $52,099 - $96,723	-11,501 Reduced 40.45%	16,934 $79,000
Q4 2023 Feb 14, 2024	BUY	$3.22 - $11.79 $91,560 - $335,248	28,435 New	28,435 $207,000
Q2 2023 Aug 14, 2023	BUY	$8.63 - $12.53 $7,188 - $10,437	833 Added 7.74%	11,601 $122,000
Q1 2023 May 15, 2023	SELL	$9.32 - $15.06 $162,438 - $262,480	-17,429 Reduced 61.81%	10,768 $105,000
Q4 2022 Feb 14, 2023	BUY	$12.5 - $18.13 $352,462 - $511,211	28,197 New	28,197 $414,000
Q3 2020 Nov 17, 2020	SELL	$21.55 - $33.92 $541,745 - $852,714	-25,139 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$30.8 - $32.99 $774,281 - $829,335	25,139 New	25,139 $780,000

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $119M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.